Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global protein-ligand binding affinity profiling via photocatalytic labeling.

Nature communications·2026
Same author

SPEN loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and therapeutic vulnerabilities.

Cancer discovery·2026
Same author

Gas Phase Separation of Modified Peptides for Activity-Based Protein Profiling.

Analytical chemistry·2025
Same author

Global Protein-Ligand Binding Affinity Profiling via Photocatalytic Labeling.

bioRxiv : the preprint server for biology·2025
Same author

μMap-FFPE: A High-Resolution Protein Proximity Labeling Platform for Formalin-Fixed Paraffin-Embedded Tissue Samples.

Journal of the American Chemical Society·2025
Same author

μMap-Interface: Temporal Photoproximity Labeling Identifies F11R as a Functional Member of the Transient Phagocytic Surfaceome.

Journal of the American Chemical Society·2024

Related Experiment Video

Updated: Jun 29, 2025

"Cell Surface Capture" Workflow for Label-Free Quantification of the Cell Surface Proteome
06:31

"Cell Surface Capture" Workflow for Label-Free Quantification of the Cell Surface Proteome

Published on: March 24, 2023

2.3K

Elucidating the Cell Surfaceome to Accelerate Cancer Drug Development.

Jacob B Geri1, William Pao2

  • 1Department of Pharmacology, Weill Cornell Medicine, Cornell University, New York, New York.

Cancer Discovery
|April 4, 2024
PubMed
Summary
This summary is machine-generated.

Identifying more cell surface proteins is crucial for developing new cancer therapies. Intensified research into the cell surfaceome will accelerate the discovery of novel therapeutic targets for cancer drug development.

More Related Videos

Glycopeptide Capture for Cell Surface Proteomics
10:11

Glycopeptide Capture for Cell Surface Proteomics

Published on: May 9, 2014

11.3K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.6K

Related Experiment Videos

Last Updated: Jun 29, 2025

"Cell Surface Capture" Workflow for Label-Free Quantification of the Cell Surface Proteome
06:31

"Cell Surface Capture" Workflow for Label-Free Quantification of the Cell Surface Proteome

Published on: March 24, 2023

2.3K
Glycopeptide Capture for Cell Surface Proteomics
10:11

Glycopeptide Capture for Cell Surface Proteomics

Published on: May 9, 2014

11.3K
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.6K

Area of Science:

  • Oncology
  • Proteomics
  • Drug Discovery

Background:

  • Cell surface proteins are accessible targets for antibody, T cell, and radiation therapies.
  • Currently, only 25 cell surface targets have approved cancer therapies in the US or EU.
  • A limited number of targets hinders the development of effective cancer treatments.

Purpose of the Study:

  • To highlight the unmet need for novel cell surface protein targets in cancer therapy.
  • To advocate for comprehensive mapping of the cell surfaceome.
  • To accelerate the development of new cancer drugs by expanding the target repertoire.

Main Methods:

  • This is a commentary, not a research study; therefore, no specific methods were employed.
  • The commentary discusses the current landscape of cell surface protein targets.
  • It emphasizes the need for future research and discovery.

Main Results:

  • There is a significant gap between the potential of cell surface proteins as therapeutic targets and the number of approved drugs.
  • The limited number of validated targets restricts therapeutic options for cancer patients.
  • A comprehensive understanding of the cell surfaceome is lacking.

Conclusions:

  • Mapping the cell surfaceome is essential for advancing cancer drug development.
  • Increased research efforts are needed to identify and validate new cell surface targets.
  • Expanding the repertoire of therapeutically relevant cell surface proteins will improve patient outcomes.